We are live on ! Find out more
VINC

Vincerx Pharma, Inc. Common Stock

Delisted

VINC was delisted on the 22nd of April, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$2.08M -$39 -2 -0%
SRC
2
Sage Rhino Capital
California
$1.72M +$16K +824 +1%
Bank of America
3
Bank of America
North Carolina
$1.47M +$1.41M +72,457 +38,541%
LFCM
4
Long Focus Capital Management
Puerto Rico
$1.11M
RSCM
5
Rock Springs Capital Management
Maryland
$901K
Vanguard Group
6
Vanguard Group
Pennsylvania
$519K -$6.63K -342 -1%
ECM
7
ExodusPoint Capital Management
New York
$393K -$35.8K -1,848 -9%
KCM
8
Kingdon Capital Management
New York
$389K
RCMNY
9
Rubric Capital Management (New York)
New York
$358K
Point72 Asset Management
10
Point72 Asset Management
Connecticut
$348K
TC
11
Tejara Capital
United Kingdom
$236K
Citadel Advisors
12
Citadel Advisors
Florida
$174K -$477K -24,585 -74%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$159K +$16.6K +858 +13%
Renaissance Technologies
14
Renaissance Technologies
New York
$134K -$25.4K -1,310 -16%
Walleye Capital
15
Walleye Capital
New York
$118K -$19.4K -1,000 -15%
SSA
16
Schonfeld Strategic Advisors
New York
$115K -$473K -24,382 -81%
SCM
17
Sio Capital Management
New York
$103K
CC
18
Clearline Capital
New York
$99.9K
BlackRock
19
BlackRock
New York
$64.9K -$1.63K -84 -3%
SM
20
Sabby Management
Florida
$57.9K -$44.4K -2,287 -44%
State Street
21
State Street
Massachusetts
$44.4K
Acadian Asset Management
22
Acadian Asset Management
Massachusetts
$42K
T. Rowe Price Associates
23
T. Rowe Price Associates
Maryland
$42K +$38.8K +2,000 New
Millennium Management
24
Millennium Management
New York
$38.2K -$21.3K -1,099 -37%
Northern Trust
25
Northern Trust
Illinois
$25.9K